• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·SCTX
Share

Scribe Therapeutics Inc. Stocks

$ 22.06Last Updated 04.08.2026

Issuer Rating

Performance

Very poor

Risk

Considerable

Recommendation

Sell

Market Cap

$ 334.16M

$ 22.06
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

01.08.2026 16:01

Small caps last week: Cathie Wood’s Scribe bet, deals to acquire Forte Bio and CBIZ

27.07.2026 16:15

Cathie Wood's ARK Genomic Revolution ETF buys newly public biotech Scribe

24.07.2026 14:59

IPO Scribe: Shares in a biotech company backed by Eli Lilly and Sanofi are now available

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

05.08.2026 16:01

A mid-cap Bitcoin mining company announced its largest deal to date. What does Anthropic have to do with this?

05.08.2026 15:41

Morning in New York: Market News Will Exacerbate Volatility

05.08.2026 15:00

Attovia IPO: Shares in the biotech company, backed by Goldman Sachs, are now available

05.08.2026 14:43

Axios has learned details about the deal between the U.S. and Iran: it is supposed to keep the Strait of Hormuz open for 60 days

05.08.2026 13:24

AMD shares plummeted 9% following Musk's decision to source only Nvidia chips for SpaceX

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026